Trial Outcomes & Findings for Smoke-free Home Intervention in Permanent Supportive Housing (NCT NCT04855357)
NCT ID: NCT04855357
Last Updated: 2026-05-29
Results Overview
The proportion of resident-participants who self-reported a voluntary adoption of smoke-free homes for \>=90 days at 6 months follow-up will be reported.
COMPLETED
NA
452 participants
6 months
2026-05-29
Participant Flow
This study is designed as an intent-to-treat model so all resident-participants who completed the baseline assessment will be included in the outcome measures. Trained location staff-participants who were enrolled in the study were not included in any analysis but were consented to participate in the study and included in Participant Flow, Baseline, and Adverse Event tables.
Unit of analysis: Permanent supportive housing (PSH)
Participant milestones
| Measure |
Smoke-free Home Permanent Supportive Housing (PSH) Resident Intervention + Staff Intervention
Study staff will deliver a one hour, one-on-one counseling to permanent supportive housing (PSH) resident-participants that includes: (1) a step-by-step guide on how to voluntarily adopt a smoke-free home, (2) information on second hand smoke (SHS) and third-hand smoke, alternative combustible tobacco and nicotine product use, cannabis-tobacco co-use, effects of SHS on kids and pets,(3) a worksheet on calculating personal costs related to tobacco use, and (4) pledges to designate one's home smoke-free. Staff at various sites will be trained by the study team (staff-participants) to provide support to the resident-participants in tobacco cessation. At follow-up assessments, the study team will ask resident-participants whether they had a chance to view the intervention materials in between visits and will offer an opportunity for resident-participants to discuss conflicts that they had experienced around smoke-free home adoption and will provide strategies to address these roadblocks.
|
Wait-List Control (Usual Care)
The current standard of care includes no interventions for smoke-free home adoption or referrals to smoking cessation resources. Wait-list group will be given the option to receive Smoke-Free Home (SFH) intervention after intervention group completes the 6-month follow-up.
|
|---|---|---|
|
Baseline
STARTED
|
226 20
|
226 20
|
|
Baseline
Resident-Participants
|
191 20
|
209 20
|
|
Baseline
Staff-Participants
|
35 13
|
17 7
|
|
Baseline
COMPLETED
|
226 20
|
226 20
|
|
Baseline
NOT COMPLETED
|
0 0
|
0 0
|
|
Month 6
STARTED
|
201 20
|
197 20
|
|
Month 6
Resident-Participants
|
171 20
|
184 20
|
|
Month 6
Staff-Participants
|
30 13
|
13 7
|
|
Month 6
COMPLETED
|
201 20
|
197 20
|
|
Month 6
NOT COMPLETED
|
0 0
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Baseline data is reported by participant type.
Baseline characteristics by cohort
| Measure |
Smoke-free Home Permanent Supportive Housing (PSH) Resident Intervention + Staff Intervention
n=226 Participants
Study staff will deliver a one hour, one-on-one counseling to PSH resident-participants that includes: (1) a step-by-step guide on how to voluntarily adopt a smoke-free home, (2) information on second hand smoke (SHS) and third-hand smoke, alternative combustible tobacco and nicotine product use, cannabis-tobacco co-use, effects of SHS on kids and pets,(3) a worksheet on calculating personal costs related to tobacco use, and (4) pledges to designate one's home smoke-free. Staff at various sites will be trained by the study team (staff-participants) to provide support to the resident-participants in tobacco cessation. At follow-up assessments, the study team will ask resident-participants whether they had a chance to view the intervention materials in between visits and will offer an opportunity for resident-participants to discuss conflicts that they had experienced around smoke-free home adoption and will provide strategies to address these roadblocks.
|
Wait-List Control (Usual Care)
n=226 Participants
The current standard of care includes no interventions for smoke-free home adoption or referrals to smoking cessation resources. Wait-list group will be given the option to receive Smoke-Free Home (SFH) intervention after intervention group completes the 6-month follow-up.
|
Total
n=452 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
Resident-Participants
|
54.97 Years
STANDARD_DEVIATION 10.07 • n=191 Participants • Baseline data is reported by participant type.
|
54.13 Years
STANDARD_DEVIATION 11.24 • n=209 Participants • Baseline data is reported by participant type.
|
54.53 Years
STANDARD_DEVIATION 10.69 • n=400 Participants • Baseline data is reported by participant type.
|
|
Age, Continuous
Staff-Participants
|
43.29 Years
STANDARD_DEVIATION 12.41 • n=35 Participants • Baseline data is reported by participant type.
|
46.88 Years
STANDARD_DEVIATION 10.59 • n=17 Participants • Baseline data is reported by participant type.
|
44.49 Years
STANDARD_DEVIATION 11.85 • n=52 Participants • Baseline data is reported by participant type.
|
|
Sex/Gender, Customized
Resident-Participants · Female
|
68 Participants
n=191 Participants • Baseline data is reported by participant type
|
62 Participants
n=209 Participants • Baseline data is reported by participant type
|
130 Participants
n=400 Participants • Baseline data is reported by participant type
|
|
Sex/Gender, Customized
Resident-Participants · Male
|
111 Participants
n=191 Participants • Baseline data is reported by participant type
|
140 Participants
n=209 Participants • Baseline data is reported by participant type
|
251 Participants
n=400 Participants • Baseline data is reported by participant type
|
|
Sex/Gender, Customized
Resident-Participants · Not Reported
|
12 Participants
n=191 Participants • Baseline data is reported by participant type
|
7 Participants
n=209 Participants • Baseline data is reported by participant type
|
19 Participants
n=400 Participants • Baseline data is reported by participant type
|
|
Sex/Gender, Customized
Staff-Participants · Female
|
20 Participants
n=35 Participants • Baseline data is reported by participant type
|
14 Participants
n=17 Participants • Baseline data is reported by participant type
|
34 Participants
n=52 Participants • Baseline data is reported by participant type
|
|
Sex/Gender, Customized
Staff-Participants · Male
|
13 Participants
n=35 Participants • Baseline data is reported by participant type
|
3 Participants
n=17 Participants • Baseline data is reported by participant type
|
16 Participants
n=52 Participants • Baseline data is reported by participant type
|
|
Sex/Gender, Customized
Staff-Participants · Not Reported
|
2 Participants
n=35 Participants • Baseline data is reported by participant type
|
0 Participants
n=17 Participants • Baseline data is reported by participant type
|
2 Participants
n=52 Participants • Baseline data is reported by participant type
|
|
Ethnicity (NIH/OMB)
Resident-Participants · Hispanic or Latino
|
33 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
29 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
62 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Ethnicity (NIH/OMB)
Resident-Participants · Not Hispanic or Latino
|
154 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
179 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
333 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Ethnicity (NIH/OMB)
Resident-Participants · Unknown or Not Reported
|
4 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
1 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
5 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Ethnicity (NIH/OMB)
Staff-Participants · Hispanic or Latino
|
6 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
9 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Ethnicity (NIH/OMB)
Staff-Participants · Not Hispanic or Latino
|
29 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
14 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
43 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Ethnicity (NIH/OMB)
Staff-Participants · Unknown or Not Reported
|
0 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
0 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
0 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · American Indian or Alaska Native
|
9 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
12 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · Asian
|
2 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
5 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · Native Hawaiian or Other Pacific Islander
|
3 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
1 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
4 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · Black or African American
|
73 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
102 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
175 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · White
|
55 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
62 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
117 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · More than one race
|
43 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
36 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
79 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Resident-Participants · Unknown or Not Reported
|
6 Participants
n=191 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
2 Participants
n=209 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
8 Participants
n=400 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · American Indian or Alaska Native
|
1 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
1 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
2 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · Asian
|
3 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
0 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
1 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
1 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · Black or African American
|
20 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
9 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
29 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · White
|
7 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
10 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · More than one race
|
1 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
4 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Race (NIH/OMB)
Staff-Participants · Unknown or Not Reported
|
3 Participants
n=35 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
0 Participants
n=17 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
3 Participants
n=52 Participants • There were two different participant populations: Resident-participants and Staff-Participants.
|
|
Region of Enrollment
United States
|
226 participants
n=226 Participants
|
226 participants
n=226 Participants
|
452 participants
n=452 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This study is designed as an intent-to-treat model so all resident-participants who completed the baseline assessment will be included in the denominator of the outcome measures.
The proportion of resident-participants who self-reported a voluntary adoption of smoke-free homes for \>=90 days at 6 months follow-up will be reported.
Outcome measures
| Measure |
Smoke-free Home Permanent Supportive Housing (PSH) Resident Intervention + Staff Intervention
n=191 Participants
Study staff will deliver a one hour, one-on-one counseling to PSH resident-participants that includes: (1) a step-by-step guide on how to voluntarily adopt a smoke-free home, (2) information on second hand smoke (SHS) and third-hand smoke, alternative combustible tobacco and nicotine product use, cannabis-tobacco co-use, effects of SHS on kids and pets,(3) a worksheet on calculating personal costs related to tobacco use, and (4) pledges to designate one's home smoke-free. Staff at various sites will be trained by the study team (staff-participants) to provide support to the resident-participants in tobacco cessation. At follow-up assessments, the study team will ask resident-participants whether they had a chance to view the intervention materials in between visits and will offer an opportunity for resident-participants to discuss conflicts that they had experienced around smoke-free home adoption and will provide strategies to address these roadblocks.
|
Wait-List Control (Usual Care)
n=209 Participants
The current standard of care includes no interventions for smoke-free home adoption or referrals to smoking cessation resources. Wait-list group will be given the option to receive Smoke-Free Home (SFH) intervention after intervention group completes the 6-month follow-up.
|
|---|---|---|
|
Proportion of Resident-participants Who Adopt a Smoke-free Home Voluntarily
|
0.068 proportion of resident-participants
|
0.048 proportion of resident-participants
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: This study is designed as an intent-to-treat model so all resident-participants who completed the baseline assessment will be included in the denominator of the outcome measures.
The proportion of resident-participants with 7-day point prevalence abstinence at 6 months follow-up, measured as self-report of abstinence and an expired carbon monoxide of \<= 5 parts per million (ppm) as abstinence will be reported.
Outcome measures
| Measure |
Smoke-free Home Permanent Supportive Housing (PSH) Resident Intervention + Staff Intervention
n=191 Participants
Study staff will deliver a one hour, one-on-one counseling to PSH resident-participants that includes: (1) a step-by-step guide on how to voluntarily adopt a smoke-free home, (2) information on second hand smoke (SHS) and third-hand smoke, alternative combustible tobacco and nicotine product use, cannabis-tobacco co-use, effects of SHS on kids and pets,(3) a worksheet on calculating personal costs related to tobacco use, and (4) pledges to designate one's home smoke-free. Staff at various sites will be trained by the study team (staff-participants) to provide support to the resident-participants in tobacco cessation. At follow-up assessments, the study team will ask resident-participants whether they had a chance to view the intervention materials in between visits and will offer an opportunity for resident-participants to discuss conflicts that they had experienced around smoke-free home adoption and will provide strategies to address these roadblocks.
|
Wait-List Control (Usual Care)
n=209 Participants
The current standard of care includes no interventions for smoke-free home adoption or referrals to smoking cessation resources. Wait-list group will be given the option to receive Smoke-Free Home (SFH) intervention after intervention group completes the 6-month follow-up.
|
|---|---|---|
|
Proportion of Resident-participants Who Achieve Abstinence
|
0.063 proportion of resident-participants
|
0.0096 proportion of resident-participants
|
Adverse Events
Smoke-free Home PSH: Resident Participants
Smoke-free Home PSH: Staff Participants
Wait-List Control (Usual Care) - Resident Participants
Wait-List Control (Usual Care)- Staff Participants
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Maya Vijayaraghavan, MD, MAS
University of California, San Francisco
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place